The American Association for the Advancement of Science (AAAS) has recently inducted 396 members as fellows, with 21 members having oncology backgrounds. Members have been awarded this honor because of their scientifically or socially distinguished efforts to advance science or its applications. New Fellows will be presented with an official certificate and a gold and blue rosette pin in February at the AAAS Fellows Forum during the 2018 AAAS Annual Meeting in Austin, Texas.
“Election to AAAS is a prestigious honor that highlights the exceptional achievements of MD Anderson’s newest Fellows,” said MD Anderson President ad Interim Marshall Hicks, MD. “We are proud to work alongside these excellent researchers who are working to improve cancer prevention, diagnosis, treatment, and education.”
The tradition of AAAS Fellows began in 1874. Currently, members can be considered for the rank of Fellow if nominated by the steering groups of the Association’s 24 sections, by any 3 Fellows who are current AAAS members (provided 2 of the 3 sponsors are not affiliated with the nominee’s institution), or by the AAAS Chief Executive Officer. Fellows must have been a continuous member of AAAS for 4 years by the end of the calendar year in which they are elected.
Oncology Fellows
- Jonathan Chernoff, MD, PhD, Senior Vice President; Chief Scientific Officer; Deputy Director; and Stanley P. Reimann Chair in Oncology Research, Fox Chase Cancer Center
- John Heymach, MD, PhD, Chair and Professor of the Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center
- Kelly Hunt, MD, Chair and Professor of the Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center
- Dimitrios Kontoyiannis, MD, PhD, Professor of Infectious Diseases, The University of Texas MD Anderson Cancer Center
- Frederick Lang, MD, Director of Clinical Research, Professor of Neurosurgery, The University of Texas MD Anderson Cancer Center
- Zhimin (James) Lu, MD, PhD, Professor of Neuro-Oncology, The University of Texas MD Anderson Medical Center
- Shao-Cong Sun, PhD, Professor of Immunology, The University of Texas MD Anderson Cancer Center
- Timothy Scott Blackwell, MD, Professor of Cancer Biology; Professor of Cell and Developmental Biology; Director of the Division of Allergy, Pulmonary and Critical Care, -Vanderbilt University School of Medicine
- Graham A. Colditz, DrPH, MD, MPH, Deputy Director of the Institute for Public Health; Chief of the Division of Public Health Sciences; and Niess-Gain Professor of Surgery, School of Medicine at Washington University, St. Louis
- Blossom Andrea Damania, PhD, Boshamer Distinguished Professor and Vice Dean for Research, University of North Carolina at Chapel Hill
- Timothy J. Eberlein, MD, Bixby Professor of Surgery; Chairman of Surgery; Spencer T. and Ann W. Olin Distinguished Professor at Washington University School of Medicine, St. Louis; Director, The Alvin J. Siteman Cancer Center; and Surgeon-in-Chief, Barnes-Jewish Hospital
- David G. Kirsch, MD, PhD, Barbara Levine University Professor; Professor and Vice Chair for Basic & Translational Research, Department of Radiation Oncology; Professor, Department of Pharmacology & Cancer Biology, Duke University Medical Center
- T. Jake Liang, MD, Chief of Liver Diseases Branch and Deputy Director of Translational Research, National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health
- Otoniel Martínez-Maza, PhD, of Jonsson Comprehensive Cancer Center, University of California, Los Angeles
- Pier Paolo Pandolfi, MD, PhD, Director of the Cancer Center and Cancer Research Institute; Chief of the Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center
- Arnold B. Rabson, MD, Professor in the Department of Molecular Genetics and Microbiology; Professor in the Department of Biochemistry and Molecular Biology, Rutgers Robert Wood Johnson Medical School
- Anil K. Rustgi, MD, T. Grier Miller Professor, Perelman School of Medicine University of Pennsylvania
- Nima Sharifi, MD, of Cancer Biology, Cleveland Clinic
- Harald zur Hausen, MD, DSc, MDs, Professor Emeritus, German Cancer Research Center.
